Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
MYOMO, INC. (MYO) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/24/2023 8-K Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive ...
Docs: "Myomo Receives Medicare Part B Reimbursement for First MyoPro® Claims Appropriate payment amounts received on two MyoPro claims; Additional claims are under review while CMS rulemaking to re-classify the MyoPro to the brace benefit category progresses BOSTON ─ Myomo, Inc. , a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it has received payments for two claims submitted for MyoPro® arm braces provided to Medicare fee-for-service beneficiaries. Myomo recently delivered the custom-fabricated MyoPro braces to these two patients. After review of the medical documentation, one of Medicare’s billing contractors, referred to as a DME MAC, has covered and paid for these two..."
08/09/2023 8-K Quarterly results
Docs: "Myomo Reports Second Quarter 2023 Financial Results Featuring Year Over Year Growth in Revenue and Operating Metrics Q2 revenue of $6.0 million, including license revenue Nearly 1,000 prospective MyoPro® candidates with known payers in the patient pipeline Begins to build Medicare Part B patient pipeline following publication of proposed rule by the Centers for Medicare and Medicaid Services Conference call begins at 4:30 p.m. Eastern time today BOSTON – Myomo, Inc. , a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three and six months ended June 30, 2023. Financial and operational highlights for the second quarter of 2023 include the following : &#x20..."
06/09/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/10/2023 8-K Quarterly results
Docs: "Myomo Reports First Quarter 2023 Financial Results Featuring 20% Year Over Year Increase in Product Revenue Implementation of virtual waiting room technology enabled a record 438 patients added to the pipeline, up 54% over Q1 2022 Advertising efficiencies resulted in cost per pipeline add of $1,579, down 50% sequentially Conference call begins at 4:30 p.m. Eastern time today BOSTON – Myomo, Inc. , a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three months ended March 31, 2023. Financial and operational highlights for the first quarter of 2023 include the following: • Product revenue was $3.4 million, up 20% compared with the prior year quarter..."
03/13/2023 8-K Quarterly results
Docs: "Myomo Reports Fourth Quarter and Full Year 2022 Financial Results Fourth quarter revenue was $4.0 million, up 2% sequentially 387 patients added to the pipeline in fourth quarter, up 75% compared with Q4 2021 Conference call begins at 10:00 a.m. Eastern time today BOSTON – Myomo, Inc. , a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three months and full year ended December, 31, 2022. Financial and operational highlights for the fourth quarter of 2022 include the following: • Product and total revenues were $4.0 million, up 2% sequentially and similar to the prior year quarter; • Revenue units were 101, up 16% sequentially and down 6% co..."
01/30/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Myomo Appoints Yitzchak Jacobovitz to its Board of Directors BOSTON - Myomo, Inc. , a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Yitzchak Jacobovitz as a Class II director effective January 27, 2023, to serve until the 2025 annual meeting of stockholders. With this appointment, Myomo has six directors. Mr. Jacobovitz, 47, is a partner and lead healthcare analyst at AIGH Capital Management and affiliates , where he has significantly grown AIGH’s healthcare footprint since joining in 2014. Prior to AIGH, Mr. Jacobovitz was a managing director at Capstone, a policy research firm and an analyst at Leap Tide Capital, a special situations hedge fund. Mr. Jacobov..."
01/13/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "NOTICE OF EXERCISE TO: MYOMO, INC. The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant , and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any. Payment shall take the form of : [ ] in lawful money of the United States; or [ ] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2, to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2. Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below: The Warrant Shares shall be deliv...",
"SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT is dated as of January 11, 2023, between Myomo, Inc., a Delaware corporation , and each purchaser identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act , the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement. NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as ...",
"137 Portland St., 4th"
01/10/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Myomo Announces Initiative to Reduce Cash Burn Undertakes a reduction in force to enhance efficiency in its direct billing channel"
12/07/2022 8-K Quarterly results
11/10/2022 8-K Quarterly results
09/27/2022 8-K Other Events  Interactive Data
08/03/2022 8-K Quarterly results
Docs: "Myomo Reports Second Quarter 2022 Financial Results and Record Number of Patient Pipeline Additions Second quarter revenue of $3.7 million up 18% over prior year Cost per pipeline addition cut in half over the last six months Conference call begins at 4:30 p.m. Eastern time today BOSTON – Myomo, Inc. , a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three and six months ended June 30, 2022. Financial and operational highlights for the second quarter of 2022 include the following: • Product revenue was $3.7 million, up 18% from Q2 2021 and up 28% sequentially; • A record 420 new candidates were added to the patient pipeline, up 52% from Q2..."
08/02/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Common Stock Purchase Agreement, between the Company and Keystone Capital Partners, LLC",
"Opinion of Goodwin Procter LLP"
07/07/2022 8-K Quarterly results
06/10/2022 8-K Quarterly results
05/11/2022 8-K Quarterly results
04/04/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Myomo Reports Progress with China Joint Venture, Receives Partial Payment of Technology License Fee BOSTON - Myomo, Inc. , a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, provides an update on the status of its joint venture in China and the associated impact on first quarter 2022 revenue. As of March 31, 2022, a portion of the technology license fee from the JV Company, Jiangxi Myomo Medical Assistive Appliance Co. Ltd., has been paid. The Company received $1.0 million of the total $2.7 million license fee during March, which will be accounted for as revenue during the three months ended March 31, 2022. David Henry, Myomo's chief financial officer, said, “This license revenue is additive to f..."
03/09/2022 8-K Quarterly results
01/10/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Myomo Provides Update on MyoPro ® Insurance Reimbursement BOSTON, Mass - Myomo, Inc. , a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today provided an update on reimbursement for its MyoPro device by a large private payer that was denying pre-authorized claims after delivery of devices to patients. For the three and nine months ended September 30, 2021, revenue from patients insured by this payer represented 32% and 30% of total revenues, respectively. As of today, approximately 90% of the claims that were denied with dates of service in September and October 2021 have been paid, either in whole or in part, and none of the appeals submitted to the payer have been denied. Although pre-authori..."
01/05/2022 8-K Entry into a Material Definitive Agreement  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
12/16/2021 8-K Quarterly results
11/10/2021 8-K Quarterly results
Docs: "Myomo Third Quarter 2021 Financial Results Feature Record Revenue"
10/15/2021 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Form of Letter Agreement",
"Myomo, Inc. Announces Agreements for Exercise of 2020 Investor Warrants"
10/05/2021 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Amendment No. 1 to Fabrication and Services Agreement, between the Company and Geauga Rehabilitation Engineering, Inc"
08/09/2021 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : August 9, 2021 Myomo, Inc. Delaware 001-38109 47-0944526 137 Portland St., 4th Floor Boston, MA 02114 Company's telephone number, including area code: 996-9058 Not applicable",
"Myomo Second Quarter 2021 Financial Results Feature Significant Increases in Revenue and Gross Margin, Record Insurance Authorizations and Orders"
06/29/2021 8-K Quarterly results
06/25/2021 8-K Quarterly results
06/15/2021 8-K Quarterly results
06/08/2021 8-K Quarterly results
05/05/2021 8-K Quarterly results
04/28/2021 8-K Quarterly results
04/06/2021 8-K Quarterly results
03/10/2021 8-K Quarterly results
01/26/2021 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : January 21, 2021 Myomo, Inc. Delaware 001-38109 47-0944526 One Broadway, 14th Floor Cambridge, MA 02142 Company's telephone number, including area code: 996-9058 Not applicable",
"Equity Joint Venture Contract, by and between Myomo, Inc. and Beijing Ryzur Medical Investment Co., Ltd.",
"Fabrication and Services Agreement, by and between Myomo, Inc. and Geauga Rehabilitation Engineering, Inc."
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy